Medical Product Development and Regulatory Policy
Projects Relating to Medical Product Development and Regulatory Policy
Project
Project
Duke-Margolis ReVAMP Drug Supply Chain Consortium
Reliable drug supply, Valuing availability, Advanced Manufacturing Technologies, and Patient-Center Focus (ReVAMP) The Consortium’s mission is to identify effective policy solutions that promote a resilient drug supply chain with advanced manufacturing capabilities and, ultimately, reduce the frequency and severity of drug shortages. Based on input from a wide range of experts involved in...
Reliable drug supply, Valuing availability, Advanced Manufacturing Technologies, and Patient-Center...
Read MoreProject
Project
Artificial Intelligence in Health Care Portfolio
Duke-Margolis AI researchers are devoted to harnessing the potential of safe, trustworthy, and responsible AI to transform health care
Duke-Margolis AI researchers are devoted to harnessing the potential of safe, trustworthy, and...
Read More
Related Work
Manufacturing quality issues, public health emergencies, natural disasters, bioterrorism, geopolitical issues, and other supply and demand shocks all pose threats to patients in need of uninterrupted access to life-saving essential drugs. Duke-Margolis developed the ReVAMP Drug Supply Chain Consortium to generate effective policy solutions that promote a reliable drug supply chain.
More information:
Emerging Initiatives - Duke-Margolis Cell and Gene Policy Initiative and Enabling the Digital Health Revolution
Project Page - Duke-Margolis ReVAMP Drug Supply Chain Consortium
Click here for more information on our work with the U.S. Food and Drug Administration
Manufacturing quality issues, public health emergencies, natural disasters, bioterrorism, geopolitical issues, and other supply and demand shocks all pose threats to patients in need of uninterrupted access to life-saving essential drugs. Duke-Margolis developed the ReVAMP Drug Supply Chain Consortium to generate effective policy solutions that promote a reliable drug supply chain.
More information:
Emerging Initiatives - Duke-Margolis Cell and Gene Policy Initiative and Enabling the Digital Health Revolution
Project Page - Duke-Margolis ReVAMP Drug Supply Chain Consortium
Events About Medical Product Development and Regulatory Policy
More EventsEvent 5/29/2025
Generic Drug Repurposing: Exploring the Potential Role of the Regulator and Policy Solutions
WASHINGTON, DC
This hybrid workshop will provide a forum for participants to discuss the potential role of the…
Read MorePublications About Medical Product Development and Regulatory Policy
More PublicationsWhite Paper
From Concept to Policy: Pull Funding for Repurposed Generic Drugs
Beth Boyer, Sarrin Chethik, Mia Williams
Beth Boyer, Sarrin Chethik, Mia Williams
2025
Read MoreWhite Paper
Barriers and Solutions Across Drug Repurposing Archetypes
Noelle Harada, Beth Boyer, David Fajgenbaum, Tanisha Carino
Noelle Harada, Beth Boyer, David Fajgenbaum, Tanisha Carino
2025
Read MoreWhite Paper
Regulatory Opportunities to Advance Generic Drug Repurposing
Mia Williams, Beth Boyer, Tanisha Carino
Mia Williams, Beth Boyer, Tanisha Carino
2025
Read MoreProject Report
Generic Drug Repurposing for Common Diseases: Proposal and Design of a Pull Mechanism
Beth Boyer, Damope Fawole, Armand Zimmerman, Coralei Neighbors
Beth Boyer, Damope Fawole, Armand Zimmerman, Coralei Neighbors
2024
Read More